<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/34088?offset=110</link>
	<atom:link href="https://bioinformaticsonline.com/related/34088?offset=110" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/37636/department-of-genetics-genomics-and-bioinformatics-national-biotechnology-development-agency-nigeria</guid>
	<pubDate>Wed, 05 Sep 2018 10:48:25 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/37636/department-of-genetics-genomics-and-bioinformatics-national-biotechnology-development-agency-nigeria</link>
	<title><![CDATA[DEPARTMENT OF GENETICS, GENOMICS AND BIOINFORMATICS, National Biotechnology Development Agency, Nigeria]]></title>
	<description><![CDATA[<p>The Genetics, Genomics &amp; Bioinformatics Department (GBBD) at NABDA is unique, encompassing all facets of modern genetics and bioinformatics research. Trans-disciplinary research being conducted in our laboratories would lead to cures for human diseases; improvements to crop and livestock quality and yield; creation of new technologies with applications to medicine; agriculture; environment; and industry.</p>
<p>Our capacity building activities covers both general and specialized topics in translational genetics, and is designed to better acquaint scientists and clinicians with the tools and technologies of genetics and genomics.</p>
<p><span>OUR RESEARCH ACTIVITIES INCLUDE:</span></p>
<div>
<ul>
<li>Biomedical Genetics: investigating genetic and environmental factors contributing to phenotypes with relevance to human health and disease.</li>
<li>Computation and Bioinformatics: develop new approaches for the management, analysis, and modelling of large, complex data sets.</li>
<li>Population and Quantitative Genetics: study of how genetic processes evolve to generate genetic variation in populations of organisms, and the effects on the patterning of variation within and between populations and specie, and</li>
<li>Genetic Engineering and Biotechnology: focuses on the research and innovation for industrial enzymes, biologics and biosimilars production.</li>
</ul>
<p>https://www.h3abionet.org/nabda</p>
</div><p>Address of the bookmark: <a href="http://www.nabda.gov.ng/departments/genetics-genomics-and-bioinformatics" rel="nofollow">http://www.nabda.gov.ng/departments/genetics-genomics-and-bioinformatics</a></p>]]></description>
	<dc:creator>BioStar</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/42470/the-new-corona-variant-has-23-mutations-in-all-which-is-unusually-huge</guid>
	<pubDate>Wed, 23 Dec 2020 03:50:50 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/42470/the-new-corona-variant-has-23-mutations-in-all-which-is-unusually-huge</link>
	<title><![CDATA[The new corona variant has 23 mutations in all, which is unusually huge !]]></title>
	<description><![CDATA[<p>The new SARS-CoV-2 version, B.1.1.7, which was first seen in the third week of September in Kent and Greater London, has since spread to other locations in the UK. According to the COVID-19 Genomics UK Consortium (COG-UK Consortium) that analysed the genome data of the virus and identified the variant, the new variant has been spreading "rapidly" over the last four weeks and has now been detected in other locations in the UK, suggesting further spread of the variant in the region.</p><p><span>According to a<span>&nbsp;</span></span><a href="https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563"><strong><span>preliminary report</span></strong></a><span><span>&nbsp;</span>posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant genomes have been sequenced. In a<span>&nbsp;</span></span><a href="https://twitter.com/TheCGPS/status/1340749351803629569"><strong><span>December 21 tweet</span></strong></a><span>, COG-UK Consortium said that it added 2,963 more genome sequences of SARS-CoV-2, of which 942 (32%) belong to the new variant. The Consortium<span>&nbsp;</span></span><a href="https://twitter.com/CovidGenomicsUK/status/1341073233420955654"><strong><span>intends to sequence</span></strong></a><span><span>&nbsp;</span>20,000 more SARS-CoV-2 genomes in the next two weeks to further ascertain the spread of the variant.</span></p><p><span>There is no clear proof, at least not yet, that it does cause severe pandemic. But there is a justification for seriously taking the possibility. Another coronavirus lineage in South Africa has acquired one specific mutation that is also present in B.1.1.7. This variant is increasingly spreading across South Africa's coastal regions. And doctors have observed in preliminary research that individuals infected with this variant bear a higher viral load-a higher concentration of the virus in their upper respiratory tract. In many viral diseases, this is associated with more severe symptoms.</span></p><p>&nbsp;</p>]]></description>
	<dc:creator>Shruti Paniwala</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/43362/machine-learning-for-genomics</guid>
	<pubDate>Thu, 09 Sep 2021 11:26:32 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/43362/machine-learning-for-genomics</link>
	<title><![CDATA[Machine Learning for Genomics]]></title>
	<description><![CDATA[<h3>Module 1: Statistics for genomics (2-8 August 2021)</h3>
<ul>
<li>A simple intro to statistical distributions</li>
<li>hypothesis testing</li>
<li>linear models.</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/stats.html">http://compgenomr.github.io/book/stats.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/compgen2021_stats.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/compgen2021_stats.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/</a></p>
<h3><a href="https://github.com/BIMSBbioinfo/compgen2021#module-2-unsupervised-learning-for-genomics-9-15-august-2021"></a>Module 2: Unsupervised learning for genomics (9-15 August 2021)</h3>
<ul>
<li>Understanding basic intuition behind machine learning approaches.</li>
<li>Using unsupervised learning to cluster and visualise data points</li>
<li>Dimension reduction techniques for visualisation and as input to clustering methods</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/unsupervisedLearning.html">http://compgenomr.github.io/book/unsupervisedLearning.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/compgen2021_unsupervisedLearning.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/compgen2021_unsupervisedLearning.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/</a></p>
<h3><a href="https://github.com/BIMSBbioinfo/compgen2021#module-3-supervised-learning-for-genomics-16-22-august-2021"></a>Module 3: Supervised learning for genomics (16-22 August 2021)</h3>
<ul>
<li>Understanding and using supervised learning methods for predictive purposes</li>
<li>How to measure prediction performance</li>
<li>Understand and use cross-validation and related concepts</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/supervisedLearning.html">http://compgenomr.github.io/book/supervisedLearning.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/compgen2021_supervisedLearning.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/compgen2021_supervisedLearning.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/</a></p>
<p>https://github.com/BIMSBbioinfo/compgen2021</p><p>Address of the bookmark: <a href="https://github.com/BIMSBbioinfo/compgen2021" rel="nofollow">https://github.com/BIMSBbioinfo/compgen2021</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</guid>
	<pubDate>Wed, 11 Dec 2024 00:59:15 -0600</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</link>
	<title><![CDATA[Understanding RNA-Seq Normalization Methods: TPM vs. FPKM vs. CPM]]></title>
	<description><![CDATA[<p>RNA sequencing (RNA-Seq) is a powerful technology used to study transcriptomes, providing insights into gene expression levels. However, raw RNA-Seq data requires normalization to account for sequencing depth and gene length, enabling accurate comparisons between genes and samples. Among the most widely used normalization methods are TPM (Transcripts Per Million), FPKM (Fragments Per Kilobase Million), and CPM (Counts Per Million). Each method has its unique principles and applications, which we&rsquo;ll explore in this blog.</p><h2>Why Normalize RNA-Seq Data?</h2><p>Normalization is a crucial step in RNA-Seq analysis for the following reasons:</p><ul>
<li>
<p><strong>Sequencing depth:</strong> Different RNA-Seq experiments produce varying numbers of reads, making direct comparisons between samples misleading.</p>
</li>
<li>
<p><strong>Gene length:</strong> Longer genes inherently generate more reads, irrespective of their actual expression level.</p>
</li>
<li>
<p><strong>Bias reduction:</strong> Normalization mitigates technical biases, enabling meaningful biological interpretation.</p>
</li>
</ul><h2>TPM (Transcripts Per Million)</h2><p>TPM measures the proportion of reads mapped to a transcript, normalized by transcript length and sequencing depth. It is calculated as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Proportionality:</strong> TPM values sum to 1,000,000 across all transcripts in a sample, making it easier to compare between samples.</p>
</li>
<li>
<p><strong>Intuitive interpretation:</strong> TPM values directly represent the abundance of transcripts in a sample.</p>
</li>
<li>
<p><strong>Preferred for comparisons:</strong> TPM facilitates between-sample comparisons better than FPKM.</p>
</li>
</ol><h2>FPKM (Fragments Per Kilobase Million)</h2><p>FPKM normalizes read counts by transcript length and sequencing depth, but without enforcing proportionality like TPM. It is defined as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Historical significance:</strong> FPKM was one of the first normalization methods used for RNA-Seq.</p>
</li>
<li>
<p><strong>Single-end vs. paired-end:</strong> In paired-end sequencing, FPKM becomes RPKM (Reads Per Kilobase Million).</p>
</li>
<li>
<p><strong>Limited utility:</strong> FPKM values are not as robust as TPM for cross-sample comparisons due to lack of proportionality.</p>
</li>
</ol><h2>CPM (Counts Per Million)</h2><p>CPM normalizes raw read counts by sequencing depth, without considering gene length. It is expressed as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Simplicity:</strong> CPM is straightforward and computationally less intensive.</p>
</li>
<li>
<p><strong>Application:</strong> Suitable for non-length-dependent analyses, such as comparing total expression levels or differential expression analysis.</p>
</li>
<li>
<p><strong>Gene length agnostic:</strong> CPM does not correct for gene length, making it less ideal for measuring expression levels.</p>
</li>
</ol><h2>When to Use Each Method</h2><ul>
<li>
<p><strong>TPM:</strong> Best for comparing expression levels between samples, especially when transcript length and sequencing depth vary.</p>
</li>
<li>
<p><strong>FPKM:</strong> Useful for historical consistency but generally replaced by TPM.</p>
</li>
<li>
<p><strong>CPM:</strong> Ideal for differential expression analysis when gene length normalization is unnecessary.</p>
</li>
</ul><h2>Conclusion</h2><p>Choosing the right normalization method depends on the specific objectives of your RNA-Seq analysis. TPM&rsquo;s proportionality and robustness make it the preferred choice for most applications, while CPM serves well for differential expression studies. Although FPKM paved the way for RNA-Seq normalization, it has largely been supplanted by TPM in modern workflows. Understanding these methods and their nuances ensures accurate and meaningful interpretations of RNA-Seq data.</p><h3>References:</h3><ol>
<li>
<p>Li, B., &amp; Dewey, C. N. (2011). RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. <em>BMC Bioinformatics.</em></p>
</li>
<li>
<p>Trapnell, C., et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. <em>Nature Biotechnology.</em></p>
</li>
<li>
<p>Law, C. W., et al. (2014). voom: precision weights unlock linear model analysis tools for RNA-seq read counts. <em>Genome Biology.</em></p>
</li>
</ol>]]></description>
	<dc:creator>Neel</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/view/1906</guid>
	<pubDate>Sun, 11 Aug 2013 11:13:58 -0500</pubDate>
	<link>https://bioinformaticsonline.com/view/1906</link>
	<title><![CDATA[Compressive Genomics]]></title>
	<description><![CDATA[<p>The key to finding a solution is to notice that most&nbsp;<a href="http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html">genomic</a>sequences differ by very little. It may well be that the number of complete genome sequences being stored is increasing rapidly, but the actual amount of new data is very small. In other words, a single DNA sequence isn't particularly compressible but a set of sequences shares so much in common that the redundancy can be used to store them in a much smaller storage space. (Source:e-article from&nbsp;Alex Armstrong)</p><p><a href="http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html">http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html</a></p><p><a href="http://en.wikipedia.org/wiki/Compression_of_Genomic_Re-Sequencing_Data">http://en.wikipedia.org/wiki/Compression_of_Genomic_Re-Sequencing_Data</a></p><p><a href="http://www.nature.com/nbt/journal/v30/n7/full/nbt.2241.html">http://www.nature.com/nbt/journal/v30/n7/full/nbt.2241.html</a></p><p><a href="http://bioinformatics.oxfordjournals.org/content/29/13/i283.full">http://bioinformatics.oxfordjournals.org/content/29/13/i283.full</a></p><p><a href="http://groups.csail.mit.edu/cb/cast/">http://groups.csail.mit.edu/cb/cast/</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/4197/bioinformatics-course-and-lectures</guid>
	<pubDate>Tue, 03 Sep 2013 16:41:02 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/4197/bioinformatics-course-and-lectures</link>
	<title><![CDATA[Bioinformatics course and lectures]]></title>
	<description><![CDATA[<p><a href="http://openwetware.org/wiki/User:Jarle_Pahr/Bioinformatics">http://openwetware.org/wiki/User:Jarle_Pahr/Bioinformatics</a></p><p>Address of the bookmark: <a href="http://gtpb.igc.gulbenkian.pt/bicourses/index.html" rel="nofollow">http://gtpb.igc.gulbenkian.pt/bicourses/index.html</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/4212/eivind-hovigs-lab</guid>
  <pubDate>Tue, 03 Sep 2013 19:06:29 -0500</pubDate>
  <link></link>
  <title><![CDATA[Eivind Hovig's Lab]]></title>
  <description><![CDATA[
<p>Bioinformatics relevant research topics are:</p>

<p>genomic scale studies<br />endogenous mechanisms of mutations, germ line and somatic <br />computational aspects of immunology in cancer <br />signalling networks<br />three-dimensional organization of information in the nucleus<br />gene silencing<br />metastatic cross-talk<br />kinase signaling<br />personalized medicine<br />detection of biomarkers in cancer <br />historical DNA variation</p>

<p>From : http://www.ous-research.no/hovig/</p>

<p>Group address:<br />Eivind Hovig, The Norwegian Radium Hospital, Montebello, 0310 Oslo,Norway<br />Email: ehovig@radium.uio.no</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/6132/computational-methods-for-the-analysis-of-the-diversity-and-dynamics-of-genomes</guid>
  <pubDate>Sat, 09 Nov 2013 20:19:02 -0600</pubDate>
  <link></link>
  <title><![CDATA[Computational Methods for the Analysis of the Diversity and Dynamics of Genomes]]></title>
  <description><![CDATA[
<p>The German-Canadian international research training group</p>

<p>"Computational Methods for the Analysis of the Diversity and Dynamics of Genomes"</p>

<p>has currently open positions for graduate students, to study at Simon Fraser University (Vancouver, Canada) and <br />Bielefeld University (Germany), starting in the fall 2014.</p>

<p>This international graduate program is a close cooperation of:</p>

<p>Bielefeld University, Germany: Graduate progam "DiDy"<br />Simon Fraser University (SFU), Vancouver, Canada: Graduate program "MADD-Gen"</p>

<p>The available positions include six PhD positions at Bielefeld University, as well as PhD and MSc positions at SFU.</p>

<p>Application deadline: December 31st, 2013<br />Webpage: http://wiki.techfak.uni-bielefeld.de/didy/Announcement</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/9676/bioinformatics-job-in-genotypic-tech-india</guid>
  <pubDate>Mon, 07 Apr 2014 08:20:54 -0500</pubDate>
  <link></link>
  <title><![CDATA[Bioinformatics job in Genotypic Tech, India]]></title>
  <description><![CDATA[
<p>Genotypic Technology, the first Genomics Company of India is poised to become the next generation life sciences company. We are hiring professionals for our high end Genomics Labs (Molecular Biology/ Microarray/NGS) and Bioinformatics groups.</p>

<p>Apply to Genotypic Technology if you are a PhD in Life Sciences/ Molecular Biology/ Biotechnology/ Human Genetics/ Bioinformatics with minimum 4-5 years post doctoral experience as well as publications in peer reviewed journals.</p>

<p>Source: http://www.genotypic.co.in/Careers/2/Current-Openings.aspx</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/22891/17-marie-curie-phd-position-available-immediately</guid>
  <pubDate>Tue, 23 Jun 2015 06:52:06 -0500</pubDate>
  <link></link>
  <title><![CDATA[17 Marie Curie PhD position available immediately]]></title>
  <description><![CDATA[
<p>Kindly look into following webpage:<br />http://medhealth.leeds.ac.uk/info/1450/scholarships/1795/marie_curie_phd_training_network</p>

<p>The closing date for application will be 26 June 2015.</p>
]]></description>
</item>

</channel>
</rss>